logo-loader
Dyadic International Inc

Dyadic International board member highlights upcoming milestones

Dyadic International Inc (NASDAQ:DYAI) board member Dr Arin Bose, a 34-year Pfizer (NYSE:PFE) veteran, talks to Proactive Investors about what went into choosing Dyadic's research partners VTT Technical Research Centre of Finland Ltd and Spain-based biotech BDI Holdings.

Dr Bose also highlighted upcoming milestones for the biotechnology platform company. To see more of Dr Bose's background, please click here

 

Quick facts: Dyadic International Inc

Price: $6.50

Market: NASDAQ
Market Cap: $176.22 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Dyadic International Inc named herein, including the promotion by the Company of Dyadic International Inc in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

'May only be a matter of time' before Uranium price recovery with...

Mining Capital's Alastair Ford discusses the planned slow down in production from Kazatomprom (LON:KAP). The miner's looking to cut output from its Kazakh mines by around 20% through to 2021. He says that extends the timeframe of its previous production curtailment by a further year, and...

1 day, 11 hours ago

2 min read